These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27489115)

  • 1. A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane.
    Frykberg RG; Gibbons GW; Walters JL; Wukich DK; Milstein FC
    Int Wound J; 2017 Jun; 14(3):569-577. PubMed ID: 27489115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human placental membrane as a wound cover for chronic diabetic foot ulcers: a prospective, postmarket, CLOSURE study.
    Pacaccio DJ; Cazzell SM; Halperin GJ; Kasper MA; Neutel JM; O'Carroll BD; Reyzelman AM
    J Wound Care; 2018 Jul; 27(Sup7):S28-S37. PubMed ID: 30008251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting.
    Raspovic KM; Wukich DK; Naiman DQ; Lavery LA; Kirsner RS; Kim PJ; Steinberg JS; Attinger CE; Danilkovitch A
    Wound Repair Regen; 2018 Mar; 26(2):213-220. PubMed ID: 29683538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM; Caporusso J; Vayser D; Davis RD; Alvarez OM; Sabolinski ML
    J Wound Care; 2024 Jul; 33(Sup7):S4-S14. PubMed ID: 38973638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viable intact cryopreserved human placental membrane for a non-surgical approach to closure in complex wounds.
    Suzuki K; Michael G; Tamire Y
    J Wound Care; 2016 Oct; 25(Sup10):S25-S31. PubMed ID: 27681807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label trial of cryopreserved human umbilical cord in the treatment of complex diabetic foot ulcers complicated by osteomyelitis.
    Marston WA; Lantis JC; Wu SC; Nouvong A; Lee TD; McCoy ND; Slade HB; Tseng SC
    Wound Repair Regen; 2019 Nov; 27(6):680-686. PubMed ID: 31376297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label Extension Phase of a Chronic Diabetic Foot Ulcer Multicenter, Controlled, Randomized Clinical Trial Using Cryopreserved Placental Membrane.
    Lavery L; Fulmer J; Shebetka KA; Regulski M; Vayser D; Fried D; Kashefsky H; Owings TM; Nadarajah J; Hesp Z
    Wounds; 2018 Sep; 30(9):283-289. PubMed ID: 30256747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective, Single-center, Open-label Case Series Evaluating the Clinical Outcomes of Lyopreserved Placental Membrane Containing Viable Cells in the Treatment of Chronic Wounds.
    Reyzelman AM; Vartivarian M; Danilkovitch A; Saunders MC
    Wounds; 2019 Apr; 31(4):97-102. PubMed ID: 30924793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers.
    Ananian CE; Dhillon YS; Van Gils CC; Lindsey DC; Otto RJ; Dove CR; Pierce JT; Saunders MC
    Wound Repair Regen; 2018 May; 26(3):274-283. PubMed ID: 30098272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective, Multicenter, Single-Arm Clinical Trial for Treatment of Complex Diabetic Foot Ulcers with Deep Exposure Using Acellular Dermal Matrix.
    Cazzell S; Moyer PM; Samsell B; Dorsch K; McLean J; Moore MA
    Adv Skin Wound Care; 2019 Sep; 32(9):409-415. PubMed ID: 31361269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M; de Freitas F; Winter M
    Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.
    Abdo RJ
    J Wound Care; 2016 Jul; 25(Sup7):S4-S9. PubMed ID: 29027851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of cryopreserved placental tissue wound matrix in the management of chronic venous leg ulcers.
    Farivar BS; Toursavadkohi S; Monahan TS; Sharma J; Ucuzian AA; Kundi R; Sarkar R; Lal BK
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):228-233. PubMed ID: 30621916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose folic acid and its effect on early stage diabetic foot ulcer wound healing.
    Boykin JV; Hoke GD; Driscoll CR; Dharmaraj BS
    Wound Repair Regen; 2020 Jul; 28(4):517-525. PubMed ID: 32141182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.
    Sabolinski ML; Capotorto JV
    J Comp Eff Res; 2019 Oct; 8(14):1229-1238. PubMed ID: 31407588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.